Alfred Cancer Trials
Clinical trials are an integral part of Alfred Cancer's research expertise and capability. Our research portfolio includes working as a lead site and well as a participating site in multiple Victorian, national and international trials.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
Alfred Cancer Trials (ACT) has extensive expertise in conducting sponsored, collaborative and investigator-led Phase I, II, III and IV clinical trials.
We work in teams. Each team consists of registered nurses and medical scientists with experience in clinical trials and cancer. The teams work together to ensure extraordinary experiences for patients who elect to join a clinical trial.
Each team has a speciality tumour focus:
- Skin & Melanoma
- Upper GI
- Head & Neck
The focus areas include early phase trials, melanoma and skin cancer trials, rare and late phase solid tumour trials.
We have expertise in managing a variety of medications to treat people with cancer:
- targeted therapy
- monoclonal antibodies
- oncolytic virus
- genetically modified organisms
Our research portfolio includes working as a lead site and well as a participating site in multiple Victorian, national and international trials.
We have access to Alfred Health research technology platforms, including the Alfred Cancer Biobank.
We pride ourselves on our ability to generate accurate and comprehensive data, ensuring we meet strict data entry timelines and sponsor expectations.
Our teams’ focus is on quality and we strive to ensure that patients receive world class care. We have established innovative models such as Teletrials, to help patients living in regional and rural areas access clinical trials.
Contact us if you are interested in becoming a sponsor.
The ClinTrial Refer app is a quick way to see all of our open trials, in one place.
It’s the easy way to find a trial that may be right for you or your patient.
Our principal investigators
Key to our teams' achievements is the support provided by our experienced and dedicated principal investigators. They have oversight of each clinical trial conducted by Alfred Cancer Trials.
Each principal investigator is an established medical oncologist with extensive expertise in the running and management of clinical trials which bring opportunities for patients to access novel and exciting cancer therapies.
Our principal investigators are supported by medical oncology research fellows, who work alongside investigators managing trials patients in clinics.
Prof Mark Shackleton is the Director of Oncology at Alfred Health.
A/Prof Andrew Haydon is a medical oncologist at Alfred Health.
Dr Sanjeev Gill is a medical oncologist at Alfred Health.
Dr Maggie Moore is a medical oncologist at Alfred Health.
Dr Ben Markman is a medical oncologist at Alfred Health.
Dr Mark Voskoboynik is a medical oncologist at Alfred Health and the Victorian Melanoma Service.
Prof John Zalcberg is a medical oncologist at Alfred Health and Head of the Cancer Research Program in the School of Public Health and Preventive Medicine at Monash University.
Dr Mitchell Chipman is a medical oncologist at Alfred Health.
Our leadership team
Clinical Research Manager, Cheryl-Ann Hawkins leads the Alfred Cancer Trials teams. Cheryl-Ann is supported by three very experienced team leaders and a study start-up coordinator.
Cheryl-Ann Hawkins is the Clinical Research Manager of Alfred Cancer Trials at Alfred Health.
Chris is the Alfred Cancer Trials team leader for early phase trials.
Shelley is the Alfred Cancer Trials team leader for melanoma and skin trials.
Kate is the Alfred Cancer Trials team leader for solid tumours.
Nikki is the Alfred Cancer Trials start up coordinator.